I want to focus this month on the progress we’ve made toward being the “leading voice promoting the field.” Overall, ASPET’s objective is to be the leading voice for pharmacology, advocating for the essential and unique role the field plays in biomedical research.
In the April 2024 issue, we highlighted the 50th anniversary of the journal Drug Metabolism and Disposition with a monthly overview of articles that celebrated the field of drug metabolism. In this second installment of the two-part series, we continue to highlight the work and accomplishments of esteemed researchers and laboratories that were published in the DMD journal in late 2023.
A Conversation with ASPET’s Secretary/Treasurer-Elect Pam Hornby, PhD
Updates from some of our outstanding ASPET members.
Sabrina Rahman Archie, PhD, focused her doctoral research on maternal and pediatric health. She specifically evaluated the potential harmful impact of maternal electronic cigarette (e-cig) use, or vaping, on postnatal health using in-vivo models. Dr. Archie’s research sparked her interest in public policy and advocacy as she recognized the urgent need for public health policy development.
A showcase of early-career scientists—what drives them and why pharmacology is important to them.
ASPET Names Three New Editorial Advisory Board Members
According to the U.S. Bureau of Labor Statistics, medical scientists, including pharmacologists, held 119,000 jobs in 2022. These jobs range anywhere from designing and conducting studies on diseases and treatment options, to writing scientific research papers for publication in respected journals. Many untold occupations fall both within and outside of this range. For pharmacologists, though the specialties are broad, the specific job areas tend to be categorized less broadly. Traditionally, career opportunities can veer toward academia, industry, government or conducting research as a bench scientist.